Zhejiang East Asia Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang East Asia Pharmaceutical has a total shareholder equity of CN¥2.0B and total debt of CN¥749.7M, which brings its debt-to-equity ratio to 37.1%. Its total assets and total liabilities are CN¥3.5B and CN¥1.5B respectively. Zhejiang East Asia Pharmaceutical's EBIT is CN¥72.5M making its interest coverage ratio -8.1. It has cash and short-term investments of CN¥294.0M.
Key information
37.1%
Debt to equity ratio
CN¥749.67m
Debt
| Interest coverage ratio | -8.1x |
| Cash | CN¥293.98m |
| Equity | CN¥2.02b |
| Total liabilities | CN¥1.50b |
| Total assets | CN¥3.52b |
Recent financial health updates
No updates
Recent updates
Zhejiang East Asia Pharmaceutical's (SHSE:605177) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 06
Zhejiang East Asia Pharmaceutical Co., Ltd.'s (SHSE:605177) Shares Lagging The Market But So Is The Business
Oct 02Zhejiang East Asia Pharmaceutical's (SHSE:605177) Solid Profits Have Weak Fundamentals
May 06Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Apr 23Take Care Before Diving Into The Deep End On Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177)
Feb 28Financial Position Analysis
Short Term Liabilities: 605177's short term assets (CN¥1.6B) exceed its short term liabilities (CN¥740.5M).
Long Term Liabilities: 605177's short term assets (CN¥1.6B) exceed its long term liabilities (CN¥756.6M).
Debt to Equity History and Analysis
Debt Level: 605177's net debt to equity ratio (22.6%) is considered satisfactory.
Reducing Debt: 605177's debt to equity ratio has increased from 4.5% to 37.1% over the past 5 years.
Debt Coverage: 605177's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 605177 earns more interest than it pays, so coverage of interest payments is not a concern.